ReCode Therapeutics to Present at Upcoming Investor Conferences in 2022

On November 22, 2022 ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, reported that Company leadership will participate in two upcoming investor conferences in November (Press release, ReCode Therapeutics, NOV 22, 2022, View Source;utm_medium=rss&utm_campaign=recode-therapeutics-to-present-at-upcoming-investor-conferences-in-2022 [SID1234624346]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Piper Sandler 34th Annual Healthcare Conference
Format: Company Presentation
Date: Tuesday, November 29, 2022
Time: 11:30 a.m. ET
Location: New York, NY

2022 RBC Capital Markets Healthcare Private Company Conference
Format: Fireside Chat
Date: Thursday, December 15, 2022
Time: 9:20 a.m. ET
Location: Virtual